Actos & Your Family

January 28, 2013

If diabetes runs in your family, circumstances may have required you to learn about the challenges of Type 2 diabetes and the medications, including Actos (pioglitazone), necessary to confront this pernicious disease. Sadly, while Actos may offer temporary relief, long-term Actos patients should be aware of the risk of this drug.

 

The U.S. Food and Drug Administration (FDA) has stated emphatically that pioglitazone treatments lasting longer than twelve months have a significantly increased likelihood of causing harm to the patient. In fact, the risk of developing bladder cancer could increase by as much as 40 percent as a result of extended pioglitazone treatments. For this reason, French and German government health advisors have strongly cautioned against Actos.

 

Want to find out what Actos may mean for your family? Your family member’s rights may have been impacted by pioglitazone treatments. To learn more, contact the professionals at Fears Nachawati today. With years of experience, we know how to help you. For a free consultation, call 1.866.545.8364 or email mn@fnlawfirm.com

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)